Discontinuation report PMS-OMEPRAZOLE DR
Report ID | 118123 |
Drug Identification Number | 02310260 |
Brand name | PMS-OMEPRAZOLE DR |
Common or Proper name | Omeprazole tablet |
Company Name | PHARMASCIENCE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OMEPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-06-15 |
Remaining supply date | 2020-06-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-06-17 | French | Compare |
v1 | 2020-06-17 | English | Compare |
Showing 1 to 2 of 2